Research Article

Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson’s Disease

Figure 2

Mitochondrial parameters at baseline and after 3 months of treatment in the placebo and melatonin groups. (a) Mitochondrial complex 1 enzyme activity as measured by the oxidation of NADH, (b) respiratory control ratio, and (c) membrane fluidity. Data of the and a are shown.
(a)
(b)
(c)